i
i
Up-to-date Information
Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html
COVID-19 serology surveillance strategy
[PDF-88.67 KB]
Details:
-
Corporate Authors:
-
Description:CDC is working with state, local, territorial, academic, and commercial partners to better understand COVID-19 in the United States. CDC has an overarching strategy for learning more about how many people have been infected with SARS-CoV-2, the virus that causes COVID-19, and how it is spreading through the U.S. population. This strategy includes using serology testing for surveillance to better understand how many infections with SARS-CoV-2 have occurred: • At different points in time, • In different locations, and • Within different populations in the United States. Serology tests look for antibodies in blood. If antibodies are found, that means there has been a previous infection. Antibodies are proteins that can fight off infections. Investigations using serology testing are called seroprevalence surveys. CDC is collaborating with public health and private partners on a variety of seroprevalence surveys of different sizes, locations, populations studied, and purposes. The seroprevalence surveys CDC is conducting include large-scale geographic surveys, community level surveys, and smaller-scale surveys focusing on specific populations in order to learn more about COVID-19.
-
Subject:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Related Documents
-
[PDF - 499.35 KB]
[PDF - 499.36 KB]
[PDF - 475.60 KB]
No Description[PDF - 533.13 KB]
[PDF - 91.83 KB]
[PDF - 662.75 KB]
[PDF - 642.07 KB]
You May Also Like
[JPEG - 174.28 KB]
[JPEG - 174.79 KB]
Email
CDC-INFO
